Dr. Ashok Kumar Vaid has a MBBS and MD in General Medicine from Government Medical College, Jammu.
He has over 41 years of clinical experience with special focus on cancer genomics, immunotherapy guidance, precision onco-therapeutics, dendritic cell therapy, and stem cell transplant.
DM in Medical Oncology from Tamil Nadu Dr. MGR Medical University, Chennai.
He is a certified Medical Oncologist with decades of accredited experience.
He has been a Postgraduate teacher registered with the National Board of Examinations.
Dr. Vaid was a university panel examiner for the super-specialty Medical Oncology course.
He is an active membership in leading medical societies such as Indian Cooperative Oncology Network, Breast Cancer Foundation of India, Indian Associate of Gynae Oncologists and IMA among others.
He is also a member of international societies such as ASCO, ESMO, EHA.
He is also on the Editorial board for Current Trends in Asian Oncology.
Dr. Ashok has authored numerous peer-reviewed articles and research papers in national and international journals.
Founded in 2009, Medanta is a leading multi-specialty hospital in India.
Accredited by NABH and NABL, ensuring top-tier healthcare standards.
Equipped with over 1,600 beds and 45+ specialties, offering a broad spectrum of medical treatments.
A pioneer in robotic surgery and cutting-edge medical technologies for complex procedures.
Known for expertise in cardiology, oncology, neurology, orthopedics, and transplant surgery.
Internationally recognized care with top doctors and surgeons from across the globe.
Combines advanced medical treatments with affordability, accessible to both local and international patients.
Ranked among India's top multi-specialty hospitals five times (2020-2024).
Best Super-Specialty Hospital in India (2021).
Won Global Health & Travel Awards and Best Hospital for Medical Tourism (2020).
Featured in Newsweek’s list of top 250 World's Best Hospitals (2024).
Best Hospital for Neurology and Neurosurgery (2018).
